Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice.
about
Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features.Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.Structural basis for the activation of acid ceramidase.
P2860
Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enzyme replacement therapy for ...... ept studies in cells and mice.
@en
Enzyme replacement therapy for ...... ept studies in cells and mice.
@nl
type
label
Enzyme replacement therapy for ...... ept studies in cells and mice.
@en
Enzyme replacement therapy for ...... ept studies in cells and mice.
@nl
prefLabel
Enzyme replacement therapy for ...... ept studies in cells and mice.
@en
Enzyme replacement therapy for ...... ept studies in cells and mice.
@nl
P2093
P2860
P1433
P1476
Enzyme replacement therapy for ...... ept studies in cells and mice.
@en
P2093
Alex Solyom
Calogera M Simonaro
Changzhi Zhu
Edward H Schuchman
Jeffrey A Medin
Shaalee Dworski
Victor DeAngelis
Xingxuan He
P2860
P356
10.1016/J.BBACLI.2017.02.001
P577
2017-02-13T00:00:00Z